Evidence map›Paper›PMID 32747754›Full record

ArticleNature chemistry2020

De novo engineering of intracellular condensates using artificial disordered proteins.

Michael Dzuricky, Bradley A Rogers, Abdulla Shahid, Paul S Cremer, Ashutosh Chilkoti

Abstract read
In one paragraph

Article in Nature chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 153 papers.

0numbers the graph read from it
0cells of the map it votes in
153citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

153 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Physics-guided design of intrinsically disordered proteins.bioRxiv : the preprint server for biology · 2026
    Article
  15. Article
  16. Article
  17. The Polymers of Life: Exploring Cellular Function Through Polymer Concepts.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  18. Article
  19. Chemical reviews · 2026
    Review
  20. Review

93 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Michael DzurickyDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.ORCID http://orcid.org/0000-0002-1775-2132
Bradley A RogersDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, USA.
Abdulla ShahidDepartment of Computer Science, Duke University, Durham, NC, USA.
Paul S CremerDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, USA.
Ashutosh ChilkotiDepartment of Biomedical Engineering, Duke University, Durham, NC, USA. chilkoti@duke.edu.

Funding

Genetically Encoded Smart Biohybrid MaterialsR35GM127042 · NIGMS · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2018 to 2022
$2.2M
NIGMS NIH HHS R35 GM127042
6 · The paper itself

Abstract

Phase separation of intrinsically disordered proteins (IDPs) is a remarkable feature of living cells to dynamically control intracellular partitioning. Despite the numerous new IDPs that have been identified, progress towards rational engineering in cells has been limited. To address this limitation, we systematically scanned the sequence space of native IDPs and designed artificial IDPs (A-IDPs) with different molecular weights and aromatic content, which exhibit variable condensate saturation concentrations and temperature cloud points in vitro and in cells. We created A-IDP puncta using these simple principles, which are capable of sequestering an enzyme and whose catalytic efficiency can be manipulated by the molecular weight of the A-IDP. These results provide a robust engineered platform for creating puncta with new, phase-separation-mediated control of biological function in living cells.

Indexed as

Amino Acid SequenceCell LineDynamic Light ScatteringEscherichia coliHumansIntrinsically Disordered ProteinsKineticsMolecular WeightMutagenesisProteomicsRecombinant ProteinsTransition TemperatureIntrinsically Disordered ProteinsRecombinant Proteins

Identifiers

PMID32747754
PMCPMC8281385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.